Company / EPS (Diluted)
Korro Bio, Inc. EPS (Diluted) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$9.37
FY2025
5-year range
-$53.08 / -$0.82
FY2021-FY2025
Trend
+82.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.82 to $-9.37 over the past 4 years.
Based on SEC 10-K filings.
-9.37 in FY2025.
Declined from $-0.82 to $-9.37 over the past 4 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 82.3% year-over-year.
- Peak eps (diluted) was recorded in FY2021.
- Lowest eps (diluted) in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$9.37 | +82.3% |
| FY2024 | -$53.08 | - |
| FY2022 | - | - |
| FY2021 | -$0.82 | +64.2% |
| FY2020 | -$2.29 | +92.0% |
| FY2019 | -$28.79 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026